期刊文献+

无血清悬浮培养舌鳞癌Tca8113细胞系及肿瘤干细胞样亚群筛选 被引量:1

Serum-free suspension culture system and screening of stem like subpopulation in Tca8113 cell line of squamous cell carcinoma
下载PDF
导出
摘要 目的:比较有血清培养基(Serum-supplemented medium,SSM)培养的细胞中和无血清培养基(Serum-free medium,SFM)培养的肿瘤干细胞球体中肿瘤干细胞样亚群的比例,以期获得较好富集肿瘤干细胞的方法。方法:SFM培养细胞,观察形成肿瘤干细胞球过程中的细胞形态;更换培养基为SSM诱导其分化;流式细胞仪检测SSM组细胞和SFM培养的肿瘤干细胞球分化前、后醛脱氢酶(Aldehyde dehydrogenase,ALDH)的表达。结果:Tca8113细胞能在SFM中存活、增殖并形成肿瘤干细胞球;SFM和SSM培养的细胞中ALDHhigh细胞比例分别为0.297 0±0.009 0和0.010 7±0.002 5,差异有统计学意义(P<0.05);诱导分化后细胞与SSM组细胞形态上无明显差异。结论:用SFM培养舌鳞癌Tca8113细胞可形成肿瘤干细胞球,而且这种细胞球富集了肿瘤干细胞。 Objective:To compare the proportion of stem like cells from serum-supplemented medium(SSM) culture with those from serum-free medium(SFM) culture in order to obtain better methods for enriching tumor stem cells.Methods: Tca8113 cells were cultivated in SFM.The cells were morphologically observed under optical microscope.To induce the differentiation of spherical cells,tumor spheres were cultivated in SSM.The expression of aldehyde dehydrogenase(ALDH) of undifferentiated spherical cel1s,post-differentiated spherical cells and SSM cells were detected by the fluorescence-activated cell sorting.Results:In SFM consisting of EGF,bFGF,and B27,a minority of Tca8113 cells could survive,proliferate,and form the suspended tumor spheres.The tumor spheres highly expressed ALDH(0.297 0±0.009 0∶0.010 7±0.002 5) and also displayed differentiation-induced abilities.No significant difference in morphology was found between the post-diferentiated spheres cells and routine cultured Tca8113 cells.Conclusion:Tumor spheres with enriched cancer stem cells can be generated under serum-free culture condition with EGF,bFGF,and B27.
出处 《重庆医科大学学报》 CAS CSCD 北大核心 2011年第12期1416-1419,共4页 Journal of Chongqing Medical University
基金 重庆市卫生局科研基金资助课题计划资助项目(编号:2008-2-231 2008-2-232)
关键词 舌鳞癌TCA8113 肿瘤干细胞球 醛脱氢酶 无血清培养基培养 tongue squamous cell carcinoma Tca8113 tumor spheres aldehyde dehydrogenase serum-free medium
  • 相关文献

参考文献15

  • 1Reya T,Morrison S J,Clarke M F,et al.Stem cells,cancer,and cancer stem cells[J].Nature,2001,414(6859):105-111.
  • 2Sell S.Stem cell origin of cancer and differentiation therapy[J].Crit Rev Oncol Hematol,2004,51(1):1-28.
  • 3Armstrong L,Stojkovic M,Dimmick I,et al.Phenotypic characterization of murine primitive hematopoietic progenitor cells isolated on basis of aldehyde dehydrogenase activity[J].Stem Cells,2004,22(7):1142-1151.
  • 4Hess D A,Meyerrose T E,Wirthlin L,et al.Functional characterization of highly purified human hematopoietic repopulating cells isolated according to aldehyde dehydrogenase activity[J].Blood,2004,104(6):1648-1655.
  • 5Chen Y C,Chen Y W,Hsu H S,et al.Aldehyde dehydrogenase 1 is a putative marker for cancer stem cells in head and neck squamous cancer[J].Biochem Biophys Res Commun,2009,385(3):307-313.
  • 6Clay M R,Tabor M,Owen J H,et al.Single-marker identification of head and neck squamous cell carcinoma cancer stem cells with aldehyde dehydrogenase[J].Head Neck,2010,32(9):1195-1201.
  • 7Corti S,Locatelli F,Papadimitriou D,et al.Identification of a primitive brain-derived neural stem cell population based on aldehyde dehydrogenase activity[J].Stem Cells,2006,24(4):975-985.
  • 8Zhang P,Zhang Y,Mao L,et al.Side population in oral squamous cell carcinoma possesses tumor stem cell phenotypes[J].Cancer Letters,2009,227(2):227-234.
  • 9Prince M E,Sivanandan R,Kaczorowski A,et al.Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma[J].Proc Natl Acad Sci USA,2007,104(3):973-978.
  • 10Clay M R,Tabor M,Owen J H,et al.Single-marker identification of head and neck squamous cell carcinoma cancer stem cells with aldehyde dehydrogenase[J].Head Neck.2010,32(9):1195-1201.

同被引文献27

  • 1Chen Y J, Chang JT, Liao CT, et al. Head and neck cancer in the betel quid chewing area: recent advances in molecular carcinogenesis.Cancer Sci. 2008;99(8): 1507-1514.
  • 2Reya T, Morrison S J, Clarke MF,et at.Stem cells, cancer, and cancer stem cells.Nature. 2001;414(6859):105-111.
  • 3Lapidot T, Sirard C, Vormoor J,et aI.A cell initiating human acute myeloid leukaemia after transplantation into SCID mice Nature. 1994;367(6464):645-648.
  • 4Dalerba P, Cho RW, Clarke MF.Cancer stem cells: models and concepts.Annu Rev Med. 2007;58:267-284.
  • 5Wei XD, Zhou L, Cheng L,et al. In vivo investigation of CD133 as a putative marker of cancer stem cells in Hep-2 cell line. Head Neck. 2009;31(1):94-101.
  • 6Clay MR, Tabor M, Owen JH,et aI.Single-marker identification of head and neck squamous call carcinoma cancer stem cells with aldehyde dehydrogenase. Head Neck. 2010;32(9): 1195-1201.
  • 7Tabor MH, Clay MR, Owen JH,et al.Head and neck cancer stem calls: the side population.Laryngoscope. 2011 ;121 (3): 527-533.
  • 8Hodgson GS, Bradley TR.Properties of haematopoietic stem cells surviving 5-fluorouracil treatment: evidence for a pre-CFU-S cell?Nature. 1979;281(5730):381-382.
  • 9Hong N J, Wright FC, Gagliardi AR,et al. Examining the potential relationship between multidisciplinary cancer care and patient survival: an international literature review.J Surg Oncol. 2010;102(2):125-134.
  • 10Wong R J, Shah JP.The role of the head and neck surgeon in contemporary multidisciplinary treatment programs for advanced head and neck cancer.Curr Opin Otolaryngol Head Neck Surg. 2010; 18(2):79-82.

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部